 Connection
Tarak Srivastava to Follow-Up Studies
This is a "connection" page, showing publications Tarak Srivastava has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.183 |
|
|
|
-
Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr. 2003 Nov; 162(11):735-51.
Score: 0.055
-
Srivastava T, Zwick DL, Rothberg PG, Warady BA. Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol. 1999 Nov; 13(9):748-54.
Score: 0.042
-
Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, Aviles D, Sreedharan R, Rheault MN, Malatesta-Muncher R, Stone H, Srivastava T, Kapur G, Baddi P, Volovelsky O, Pelletier J, Gbadegesin R, Seeherunvong W, Patel HP, Greenbaum LA. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2019 08; 34(8):1435-1445.
Score: 0.040
-
Goel SC, Tuli SM, Singh HP, Sharma SV, Saraf SK, Srivastava TP. Allogenic decalbone in the repair of benign cystic lesions of bone. Int Orthop. 1992; 16(2):176-9.
Score: 0.024
-
Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007 Feb; 22(2):282-7.
Score: 0.017
-
Tuli SM, Srivastava TP, Sharma SV, Goel SC, Gupta D, Khanna S. The bridging of large osteoperiosteal gaps using 'Decalbone'. Int Orthop. 1988; 12(2):119-24.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|